OnabotulinumtoxinA at 195 UI may be effective in reducing the number of headaches per month and medication intake in patients with chronic migraine and medication overuse.
The CaMEO study is a prospective, longitudinal web-based survey designed to characterize the impact of migraine on aspects of quality of life.
Treatment with fremanezumab may help reduce medication overuse and the number of days of acute medication use in individuals with chronic migraine.
Fremanezumab has shown efficacy in safely reducing monthly headache days in individuals with chronic migraine.
Investigators collected audio recording of physician-patient interaction during office visits to evaluate communication patterns.
Patients with chronic migraine exposed to visual stimulation may have enhanced activity in the spinal trigeminal nucleus and the right superior colliculus compared with healthy individuals.
Researchers deployed a survey to determine the extent of pain, psychiatric, endocrine, and neurologic comorbidities in patients with chronic or episodic migraine.
A year-long treatment with onabotulinumtoxin A may effectively and safely reduce the number of monthly headaches in individuals with chronic migraine, particularly in individuals with unilateral pain.
The use of onabotulinumtoxinA every 12 weeks over a 2-year period was found to be safe, and effective for headache prevention in patients with chronic migraine.
High levels of stress may be associated with poor acute treatment outcomes in patients with chronic migraine.
OnabotulinumtoxinA was shown to have a better outcome in patients with chronic migraine who start the treatment within 12 months of symptom onset.
An association was established between excessive daytime sleepiness and a high frequency of headaches.
Patients with chronic migraine share features with individuals with temporomandibular disorders that include kinesiophobia and neck disability.
In patients with chronic migraine and medication overuse, patients who frequently relapse into overuse following withdrawal have a worse clinical and psychological profile than patients who relapse less frequently.
Transcutaneous supraorbital neurostimulation provides an effective prophylactic treatment for patients with chronic migraine.
Examination of hypothalamic activity shows distinctly different patterns between episodic and chronic forms of migraine.
A combination of treatment with CBT and the tricyclic antidepressant amitriptyline led to greater improvements in youth with chronic migraine compared with treatment with headache education and amitriptyline.
Non-medication approaches such as biofeedback and cognitive behavioral therapy may be helpful adjunct therapies and may help with more long-term coping strategies.
Sixty and 35 percent of patients achieved a 30 and 50% reduction, respectively, in headache days and/or pain intensity.
Participants experienced a reduction in headache days as soon as 3 days post-treatment.
Cryoanalgesia for chronic headaches: easy to use, reversible
Effectiveness of an Anti-CGRP Antibody in Enhancing Wellness During Migraines' Prodrome and Postdrome PhasesJune 10, 2016
Anti-CGRP Antibody for Migraine
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Methadone Improves Short-Term Outcomes Better Than Morphine in Neonatal Abstinence Syndrome
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Hospital-Owned Practices Associated With Positive Workplace Perceptions Among Staff
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer